Nom du produit:dimethyl({[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
IUPAC Name:dimethyl({[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
- CAS：2369772-15-4
- Formule moléculaire：C16H26BNO2
- Pureté：95%+
- Numéro de catalogue：CM1077583
- Poids moléculaire：275.2
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2369772-15-4
- Formule moléculaire:C16H26BNO2
- Point de fusion:-
- Code SMILES:CN(C)CC1=CC=C(B2OC(C)(C)C(C)(C)O2)C(C)=C1
- Densité:
- Numéro de catalogue:CM1077583
- Poids moléculaire:275.2
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Boronic Acids and Esters
- Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).
- Boronic Acid For Sale
- Find trusted boronic acid for sale. Any requirements and problems can ask us at any time.
Column Infos
- ORIC-944
- ORIC-944 is a potent and selective allosteric inhibitor of PRC2 developed by ORIC Pharmaceuticals. Initiated dosing of ORIC-944 in combination with NUBEQA® (darolutamide) and in combination with ERLEADA® (apalutamide) in the ongoing Phase 1b trial for prostate cancer in first half of 2024. Entered into clinical trial collaboration and supply agreements with Bayer and Johnson & Johnson to support the ongoing Phase 1b trial of ORIC-944 in combinations with AR inhibitors for the treatment of prostate cancer.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
